CN1263461C - Cell growth regulatnig factor F and its prepn process - Google Patents

Cell growth regulatnig factor F and its prepn process Download PDF

Info

Publication number
CN1263461C
CN1263461C CNB021510997A CN02151099A CN1263461C CN 1263461 C CN1263461 C CN 1263461C CN B021510997 A CNB021510997 A CN B021510997A CN 02151099 A CN02151099 A CN 02151099A CN 1263461 C CN1263461 C CN 1263461C
Authority
CN
China
Prior art keywords
cell growth
phenylalanine
natural gene
regulatory factor
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021510997A
Other languages
Chinese (zh)
Other versions
CN1506063A (en
Inventor
谢旭明
谢黎升
黎景
黎智
谢昱青
朱红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changshan Hui Hui Biotechnology Co., Ltd.
Original Assignee
谢旭明
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 谢旭明 filed Critical 谢旭明
Priority to CNB021510997A priority Critical patent/CN1263461C/en
Publication of CN1506063A publication Critical patent/CN1506063A/en
Application granted granted Critical
Publication of CN1263461C publication Critical patent/CN1263461C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to natural cell growth regulating factor F and a preparation method thereof. The preparation method comprises the following steps: sieving Gram-positive cocci and Gram-negative cocci or bacilli, and freezing and preserving a strain; conventionally cultivating the strain at a temperature of 4 to 38 DEG C and leaving beneficial thallus fragments via filtration for at least one time to remove harmful thalli, namely extracting natural genes; adding a certain amount of phenylalanine in the natural genes; after safety test, sealing a water agent under a GMP standard to prepare the natural cell growth regulating factor F. 1 mu g of the natural genes of the prepared natural cell growth regulating factor F can be compounded with more than 1 mu g of phenylalanine. The natural cell growth regulating factor F can prompt a body to activate and reinforce immunological functions so as to reinforce TC, re-repair and reshape senescent, necrotic, denatured, atrophic and fiberized pancreatic tissue cells, and regenerate and replant capillary vessels to make skin re-paired, reshaped, etc.

Description

Cell growth regulatory factor F and preparation method
Technical field
What the present invention relates to is a kind of medicine and preparation method that is of value to the Growth of Biologic Cell regulation and control, belongs to a kind of biological medicine.
Background technology
The mankind, birth and old age, sickness and death are a kind of natural laws, along with wearing out of human body cell, the regeneration function of its cell will be lost gradually, human body enters aging period, and the intravital various cellular degenerations of people are had an operation as the old man and to be recovered to want the slow well evidence that is mostly more than the adolescent.The aging of people mainly shows on the cell senescence and deterioration of various internal organs, thereby in recent years, the medical expert of countries in the world is attempting to study relevant " the long-lived medicine " that increases man's lifespan.So-called long-lived medicine is exactly nothing but that this medicine can promote functions such as the enhancing of the regeneration of human body cell and repair ability and improvement.Yet the file that yet there are no similar contents such as " long-lived medicines " is published.On the other hand, even if the someone does not also enter old age, but still will there be its situation about can not normally repair of necrosis of human cell tissue in the part of its human body, as cervical spondylosis patient or prolapse of lumbar intervertebral disc patient or the like.These patients are in the majority with the older, the mechanism of its morbidity mainly still exists because degeneration, atrophy, downright bad cell fibrosis and calcified tissue have taken place in the part of its human body, conventional treatment method is exactly an excision, again plant foreign body or the corresponding tissues of transplanting such as tissue or metal then, this therapeutic method of surgery is passive, and does not have the positive therapeutic effect, and it can only be treated devastatingly, its effect is not desirable, also will produce rejection for a long time.Also have a kind of collagenase, matter acid enzyme or collagen protein of using to treat, but collagenase, matter acid enzyme and collagen protein only have dissolution to the fibrosis tissue of necrosis, but normal cell tissue there is not regeneration, effect such as repairs and mould again, thereby in fact they do not have any good curative effect of effecting a permanent cure.
At present, the research and development of microorganism medical science is very fast, people have had darker understanding to various antibacterials and virus, as publishing in " medical microorganism " university teaching material on probation of distribution in June, 1979 by the People's Health Publisher, enumerated and introduced the kind of antibacterial and virus, and the biological character of each bacterioid or the like.Each bacterioid can be realized the technical security acceptance test to the antibacterial thalline by culture medium culturing and after filtering.In existing disclosed technical data, the content introduction of pair bacteria culture media is arranged, as meat soup and broth agar culture medium, pig heart infusion protein culture medium etc.; After the cultivation by these bacteria culture medias, the antibacterial thalline can split into the thalline material of reproductive capacity, and part cracks into the bacterial chip of no reproductive capacity simultaneously, and the antibacterial thalline also can produce secretory substance and stay culture medium complex etc. in incubation.In existing disclosed technical data, the method introduction of some aseptic filtrations is also arranged, it adopts filters such as filter membrane filter, Cai's seitz filter Seitz to realize, selects the aperture of certain filter opening and conventional filter can remove some thalline materials etc.Though at present people have had darker understanding to each bacterioid, only be confined to the category understood, exist many deficiencies to how utilizing antibacterial to carry out medical research such as preventing and treating diseases, stayed many blank spots medically.
Summary of the invention
The object of the present invention is to provide and a kind of human body cell is had the adjusting and controlling growth effect, strengthen the n cell growth regulatory factor F and the preparation method of functions such as the regeneration of inside of human body cell tissue, reparation, contain natural gene, the phenylalanine that extracts in Gram-positive, negative cocci or the bacillus among this n cell growth regulatory factor F, and the configurable phenylalanine that has more than the 1 μ g of 1 μ g natural gene.
1 μ g natural gene disposes 1 μ g---the phenylalanine of 500mg among the described n cell growth regulatory factor F.
1 μ g natural gene disposes 1 among the described n cell growth regulatory factor F---the phenylalanine of 200mg.
A kind of method of producing n cell growth regulatory factor F, it is earlier Gram-positive, negative cocci or bacillus to be screened and the freezing bacterial strain, with bacterial strain 4---the conventional cultivation under 38 ℃ of temperature, and after at least once removing by filter harmful bacteria, stay useful bacterial chip etc. and promptly extract natural gene, in natural gene, quantitatively add phenylalanine, after safety detection, water preparation closes to seal and forms under the GMP standard.Described useful bacterial chip, its component comprise the genetic stew of thalline, the secretions of thalline and the culture medium complex of this thalline.Described phenylalanine is amino acid whose a kind of, can outsourcing.
Described bacterial strain is 10---the conventional cultivation under 35 ℃ of temperature, and after secondary filter is removed harmful bacteria at least, stay useful bacterial chip and promptly extract natural gene.
The present invention is by screening Gram-positive, negative cocci or bacillus, through cultivating, filter removal impurity and harmful substance, as the thalline that causes a disease, the useful bacterial chip that extraction stays is a natural gene, so-called natural gene is meant that filtrate such as useful bacterial chip do not change its molecular structure and chemical physical property, thereby be natural, institute's tht gene is meant that useful bacterial chip is a kind of little thalline measurement unit; This useful natural gene has the adjusting and controlling growth effect to human body cell, groups of cells to necrosis is woven with reparation and shaping action more again, after itself and phenylalanine be mixed and made into n cell growth regulatory factor F, both have synergism, its effect will be more obvious, have and better impel body to activate raise immunity, TC is strengthened, and necrosis, degeneration, atrophy, Fibrotic histiocyte are repaired again, mould again, blood capillary regeneration, grow again, thereby play skin and soft tissue is repaired, shaping action more again.
The commodity of n cell growth regulatory factor F of the present invention are by name: reveal and grow rainbow, and to the treatment epithelial damage, fester, skin injury, old cicatrixes such as the burn of a variety of causes, scald are effective in cure.Through animal safety test, acute, subacute toxicity test is negative, undue toxicity, long term toxicity test feminine gender.Model case: case 1, male, 25 years old, the most of mummification necrosis far-end of right middle finger 3.5cm exposed bone before the medication.Through the made Drug therapy of the present invention, slough comes off after 3 months, expands wound epithelium posterius ankylose, no cicatrization.
Case 2, leaf XX, women, 22 years old, facial burn II-III degree 20 years, anaphalantiasis, right side facial deformity.After the medication treatment, cicatrix progressively disappears, and eyebrow is progressively grown, among the after treatment regularly.
Case 3, clock XX, the women, face is got injured by a fall, deformity, the walking of can not going out, mood is very painful; Recovery from illness after treating, no cicatrix line.
Case 4, Jiang XX, 9 years old, facial wound, the right face cheekbone exposes, the necrosis of postoperative skin bit, and it is damaged to press 3X3CM skin and flesh.After the medication treatment, flap regeneration, healing is normal.
The specific embodiment
The present invention will be described in detail below in conjunction with embodiment:
Embodiment 1, earlier gram-positive cocci is screened and the freezing bacterial strain, with bacterial strain conventional cultivation under 4 ℃ of temperature, the general low more incubation time of temperature is long more, bacterial strain stays useful bacterial chip after successively removing by filter impurity and harmful bacteria four times after fully cultivating, be the extraction natural gene, because the gram coccus is a bacterial strain in spite of illness common in the clinical medicine, the public can conveniently get from public occasion, as sample for test of being provided in the laboratory of various big hospital etc., therefore it does not need special preservation department to carrying out preservation in the bacterium, and it can reach the purpose of place to go disease carrying germ through after cultivating fully and filtering.Getting useful bacterial chip is natural gene 1 μ g, quantitatively adds the 1mg phenylalanine therein, measures content and after safety detection, water preparation or freezing dry powder close envelope and form n cell growth regulatory factor F under the GMP standard, after product inspection is qualified, and printing package.
Embodiment 2, earlier Gram-negative coccus is screened and the freezing bacterial strain, with bacterial strain conventional cultivation under 9 ℃ of temperature, bacterial strain stays useful bacterial chip after successively removing by filter impurity and harmful bacteria three times after fully cultivating, be the extraction natural gene; Getting useful bacterial chip is natural gene 1 μ g, quantitatively adds the 3mg phenylalanine therein, measures content and after safety detection, water preparation or freezing dry powder close envelope and form n cell growth regulatory factor F under the GMP standard, after product inspection is qualified, and printing package.
Embodiment 3, earlier gram negative bacilli is screened and the freezing bacterial strain, with bacterial strain conventional cultivation under 20 ℃ of temperature, bacterial strain stays useful bacterial chip after removing impurity and harmful bacteria through the priority secondary filter after the abundant cultivation, be the extraction natural gene; Getting useful bacterial chip is natural gene 1 μ g, quantitatively adds the 8mg phenylalanine therein, measures content and after safety detection, water preparation or freezing dry powder close envelope and form n cell growth regulatory factor F under the GMP standard, after product inspection is qualified, and printing package.
Embodiment 4, earlier Gram-positive bacillus is screened and the freezing bacterial strain, with bacterial strain conventional cultivation under 38 ℃ of temperature, bacterial strain stays useful bacterial chip through after once removing by filter impurity and harmful bacteria after fully cultivating, be the extraction natural gene, it is many more normally to filter number of times, and the useful bacterial chip of left (extraction) is that gene is just pure more.Getting useful bacterial chip is natural gene 1 μ g, quantitatively adds the 20mg phenylalanine therein, measures content and after safety detection, water preparation or freezing dry powder close envelope and form n cell growth regulatory factor F under the GMP standard, after product inspection is qualified, and printing package.
Other embodiment all can dispose 1 μ g at gene 1 μ g---arbitrarily configuration in the scope of 500mg phenylalanine.

Claims (4)

1, a kind of n cell growth regulatory factor F, it is characterized in that containing natural gene, the phenylalanine that extracts in Gram-positive, negative cocci or the bacillus among this n cell growth regulatory factor F, wherein 1 μ g natural gene disposes 1 μ g---the phenylalanine of 500mg.
2, n cell growth regulatory factor F according to claim 1 is characterized in that among the described n cell growth regulatory factor F, 1 μ g natural gene disposes 1---the phenylalanine of 200mg.
3, a kind of method of producing as claim 1 or 2 described n cell growth regulatory factor F, it is earlier Gram-positive, negative cocci or bacillus to be screened and the freezing bacterial strain, with bacterial strain 4---the conventional cultivation under 38 ℃ of temperature, and after at least once removing by filter harmful bacteria, stay useful bacterial chip and promptly extract natural gene, in natural gene, quantitatively add phenylalanine, after safety detection, water preparation or freezing dry powder close to seal and form under the GMP standard.
4, the method for n cell growth regulatory factor F according to claim 3 is characterized in that described bacterial strain is 10---the conventional cultivation under 35 ℃ of temperature, and after secondary filter is removed harmful bacteria at least, stay useful bacterial chip and promptly extract natural gene.
CNB021510997A 2002-12-06 2002-12-06 Cell growth regulatnig factor F and its prepn process Expired - Fee Related CN1263461C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB021510997A CN1263461C (en) 2002-12-06 2002-12-06 Cell growth regulatnig factor F and its prepn process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB021510997A CN1263461C (en) 2002-12-06 2002-12-06 Cell growth regulatnig factor F and its prepn process

Publications (2)

Publication Number Publication Date
CN1506063A CN1506063A (en) 2004-06-23
CN1263461C true CN1263461C (en) 2006-07-12

Family

ID=34234256

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021510997A Expired - Fee Related CN1263461C (en) 2002-12-06 2002-12-06 Cell growth regulatnig factor F and its prepn process

Country Status (1)

Country Link
CN (1) CN1263461C (en)

Also Published As

Publication number Publication date
CN1506063A (en) 2004-06-23

Similar Documents

Publication Publication Date Title
US11884953B2 (en) Method for preparing protein peptide based on connective tissue and prepared protein peptide and use thereof
CN104163847A (en) Housefly larvae active protein peptide preparation method and housefly larvae active protein peptide prepared thereby and purpose of housefly larvae active protein peptide
CN1263461C (en) Cell growth regulatnig factor F and its prepn process
JPS62236499A (en) Biologically active polypeptide and its production and composition containing the same
CN1323669C (en) Cell growth regulating factor P and its prepn process
CN1263460C (en) Cell growth regulating factor G and its prepn process
CN1235594C (en) Cell growth regulating factor Q and its prepn process
CN1235593C (en) Regulatary factor T for cell growth, and its prepn. method
CN1323670C (en) Cell growth regulatory factor L and preparing process thereof
CN1241575C (en) Cell growth regulating factor U and its prepn process
CN1263459C (en) Cell growth regulating factor O and its prepn process
CN1305465C (en) Cell growth regulating factor I and its prepn process
CN1255113C (en) Cell growth regulating factor D and its prepn process
CN1293875C (en) Cell growth regulatnig factor S and its prepn process
CN1293866C (en) Cell growth regulating factor II and its prepn process
CN1233328C (en) Cell growth regulating factor K and its prepn process
CN1323672C (en) Cell growth regulatory factor C and preparing process thereof
CN1044468A (en) Cell growth stimulant and manufacture method thereof
CN1323671C (en) Cell growth regulating factor J and its prepn process
CN1293865C (en) Cell growth regulating factor R and its prepn process
CN1245164C (en) Cell growth regulating factor oral liquid and its prepn process
CN1506052A (en) Cell growth regulating factor X and its prepn process
CN1424045A (en) Cell growth regulating factor B and preparation thereof
CN1421211A (en) Cell growth regulating factor M and its prepn process
CN100360185C (en) Preparation method of medicine for treating pelada

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: CHANGSHAN HUIYONG BIOTECHNOLOGY CO., LTD.

Free format text: FORMER OWNER: XIE XUMING

Effective date: 20101126

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 310013 HANGZHOU XUMING BONE FRACTURE CURE CENTER, NO.40, LONGJING ROAD, HANGZHOU CITY, ZHEJIANG PROVINCE TO: 324211 JUJIA VILLAGE, HEJIA TOWNSHIP, CHANGSHAN COUNTY, ZHEJIANG PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20101126

Address after: The village of 324211 Zhejiang County in Changshan province where the hometown Ju

Patentee after: Changshan Hui Hui Biotechnology Co., Ltd.

Address before: Hangzhou City, Zhejiang province 310013 No. 40 Longjing Road, Hangzhou Xuming orthopedics treatment center

Patentee before: Xie Xuming

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060712

Termination date: 20201206